{"result": "(\"entity\"<|>NUTRICIÓN PARENTERAL<|>EVENT<|>Nutritional support provided intravenously to patients unable to use their digestive system, often used pre-operatively or during chemotherapy for severe malnutrition)\n##\n(\"entity\"<|>HIPODERMOCLISIS<|>EVENT<|>A method of subcutaneous rehydration that is preferred when oral intake is restricted, involving the administration of fluids through the skin)\n##\n(\"entity\"<|>ALPERS DH<|>PERSON<|>Author of a study on nutritional considerations in wasting diseases, contributing to the field of nutritional therapeutics)\n##\n(\"entity\"<|>ASPEN BOARD OF DIRECTORS<|>ORGANIZATION<|>A governing body that provides guidelines for the use of parenteral and enteral nutrition in patients)\n##\n(\"entity\"<|>BARRERA R<|>PERSON<|>Author of a study on nutritional support in cancer patients, contributing to the field of nutritional therapeutics)\n##\n(\"entity\"<|>DE BLAUW I<|>PERSON<|>Author of a study on metabolic changes in cancer anorexia, contributing to the field of nutritional therapeutics)\n##\n(\"entity\"<|>GISBERT AGUILAR A<|>PERSON<|>Author of a study on asthenia, cachexia, anorexia, and dehydration, contributing to the field of palliative care)\n##\n(\"entity\"<|>PLANAS DOMINGO J<|>PERSON<|>Author of a study on cachexia-anorexia, contributing to the field of nutritional therapeutics)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL<|>HIPODERMOCLISIS<|>Both are methods of providing nutritional support and hydration to patients with specific medical needs<|>7)\n##\n(\"relationship\"<|>ASPEN BOARD OF DIRECTORS<|>NUTRICIÓN PARENTERAL<|>The ASPEN Board of Directors provides guidelines for the use of parenteral nutrition<|>8)\n##\n(\"relationship\"<|>ALPERS DH<|>NUTRICIÓN PARENTERAL<|>Alpers DH's work contributes to understanding nutritional considerations in conditions requiring parenteral nutrition<|>6)\n##\n(\"relationship\"<|>BARRERA R<|>NUTRICIÓN PARENTERAL<|>Barrera R's research on nutritional support in cancer patients relates to the use of parenteral nutrition<|>6)\n##\n(\"relationship\"<|>DE BLAUW I<|>NUTRICIÓN PARENTERAL<|>De Blaauw I's study on metabolic changes in cancer anorexia is relevant to the nutritional needs addressed by parenteral nutrition<|>6)\n##\n(\"relationship\"<|>GISBERT AGUILAR A<|>NUTRICIÓN PARENTERAL<|>Gisbert Aguilar A's research on dehydration and nutritional support is relevant to the context of parenteral nutrition<|>6)\n##\n(\"relationship\"<|>PLANAS DOMINGO J<|>NUTRICIÓN PARENTERAL<|>Planas Domingo J's work on cachexia-anorexia is related to the nutritional interventions like parenteral nutrition<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: proteicos en caso de malnutrición severa. Estudios recientes plantean la utilidad de las dietas enterales enriquecidas en glutamina. Aunque los aportes de vitaminas y micronutrientes suele estar bien cubiertos con una dieta estandard, han de suplementarse los déficits preexistentes tanto vitamínicos como de oligoelementos (zinc especialmente).\n\n## 4.- NUTRICIÓN PARENTERAL\n\nSu indicación principal es la imposibilidad de utilizar el tubo digestivo, aunque también se ha administrado de forma pre-operatoria en pacientes con desnutrición severa, y en pacientes que vayan a ser sometidos a quimio o radioterapia previamente desnutridos. En estos casos la nutrición parenteral ha demostrado ser efectiva aumentando el peso o disminuyendo su pérdida.\n\nLa composición de la nutrición parenteral no varía con respecto a otros pacientes, dependiendo fundamentalmente de la situación clínica individual. En condiciones normales, se administrarán soluciones estándar, pudiendo estar indicado, al igual que en nutrición enteral, la suplementación con glutamina en forma de dipéptidos, sobre todo en los casos con enteritis por irradiación o en el trasplante de células progenitoras hemopoyéticas.\n\n## 5.- HIDRATACIÓN\n\nLa decisión de hidratar a un paciente artificialmente debe implicar al paciente, a su familia y cuidadores.\n\nLa modalidad de rehidratación, dependiendo del déficit de volumen plasmático, debe adecuarse al tipo de fluídos, al volumen y la vía de administración:\n\n| VÍA DE ADMINISTRACIÓN | INDICACIONES | OPCIONES |\n|------------------------|---------------|----------|\n| INTRAVENOSA | Contraindicada vía SC | Periférica o central |\n| SUBCUTÁNEA (hipodermoclisis) | De elección ante restricción de vía oral | Contínua 24h<br>Nocturna 12 h<br>Bolo de 500 ml en 1 hora<br>(2-3 veces / día) |\n| ENTERAL | Disfagia y tumores de cabeza y cuello | SNG (inferior a 2 meses)<br>Gastrostomía (superior a dos meses) |\n---\n| PROCTOLISIS | Restricción de vía oral de tras vías Contraindicado en cáncer de colon | Infusión intermitente Agua o suero fisiológico |\n|-------------|--------------------------------------------------|------------------------------------------|\n\nLa HIPODERMOCLISIS como vía de elección:\n\nEl punto de inyección subcutáneo precisa cambio cada 4-5 días en relación con procesos inflamatorios o hemorrágicos que disminuyen su absorción.\n\nLos fluidos recomendados son el suero salino fisiológico ó dextrosa al 5%, pudiendo añadir hasta 30 mEq de potasio /L en los casos de hipopotasemia, con buena tolerancia local.\n\nEl volumen necesario, calculado como el volumen diario de orina más 500 cc de pérdidas insensibles, se estima en torno a un litro al día.\n\n## CONSIDERACIONES ÉTICAS\n\nLa buena práctica clínica en la decisión de NUTRIR / HIDRATAR a un paciente que recibe cuidados paliativos, parte de la decisión consensuada con el paciente y su familia.\n\nEn términos generales, si el pronóstico vital es mayor de un mes y/ la depleción ha sido muy rápida, debemos explicar detalladamente las ventajas e inconvenientes de la intervención, orientada siempre hacia el mayor confort del enfermo.\n\nSi la situación terminal se encuentra próxima a la fase agónica, evitar la intervención, realizar cuidados e higiene de la boca y respetar siempre la autonomía del paciente y de su familia.\n---\n# BIBLIOGRAFIA\n\n1. Alpers DH. Nutritional considerations in wasting diseases. En: Alpers SH, Stenson WF, Bier D, editors. Manual of Nutritional Therapeutics. Philadelphia: Lippincot Williams Wilkins; 2002. p. 535-51.\n\n2. ASPEN Board of Directors. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr. 2002;26:1SA-138SA.\n\n3. Barrera R. Nutritional support in cancer patients. JPEN J Parenter Enteral Nutr. 2002; 26: 63-71.\n\n4. De Blaauw I, Deutz M, Von Meyenfeldt MF. Metabolic changes in cancer anorexia. Clin Nutr. 1997;16:169-76.\n\n5. Gisbert Aguilar A. Astenia, caquexia, anorexia y deshidratación. En: Sanmartín Moreira J, editor. Guías clínicas de cuidados paliativos. Madrid: Aran; 2007. p. 117-30.\n\n6. Planas Domingo J. Caquexia-anorexia. En: Porta Sales J, Gómez Batiste X, Tuca Rodríguez A, editores.\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}